Feedback / Questions
Prevymis (letermovir) - Merck (MSD)
Letermovir prophylaxis and cytomegalovirus immune monitoring: Toward a win-win strategy in heart transplantation.
(PubMed, J Heart Lung Transplant)
-
Nov 7, 2025 -
No abstract available
Journal
•
Cytomegalovirus Infection • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/41201427
Gregor Poglajen
Nov 7, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next